vs

Side-by-side financial comparison of BREAD FINANCIAL HOLDINGS, INC. (BFH) and Steris (STE). Click either name above to swap in a different company.

Steris is the larger business by last-quarter revenue ($1.5B vs $975.0M, roughly 1.5× BREAD FINANCIAL HOLDINGS, INC.). On growth, Steris posted the faster year-over-year revenue change (9.2% vs 5.4%). Over the past eight quarters, Steris's revenue compounded faster (15.8% CAGR vs -0.8%).

Bread Financial Holdings, Inc. is an American publicly traded provider of private label credit cards, coalition loyalty programs, and direct marketing, derived from the capture and analysis of transaction-rich data.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

BFH vs STE — Head-to-Head

Bigger by revenue
STE
STE
1.5× larger
STE
$1.5B
$975.0M
BFH
Growing faster (revenue YoY)
STE
STE
+3.8% gap
STE
9.2%
5.4%
BFH
Faster 2-yr revenue CAGR
STE
STE
Annualised
STE
15.8%
-0.8%
BFH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
BFH
BFH
STE
STE
Revenue
$975.0M
$1.5B
Net Profit
$192.9M
Gross Margin
43.8%
Operating Margin
4.9%
18.3%
Net Margin
12.9%
Revenue YoY
5.4%
9.2%
Net Profit YoY
11.2%
EPS (diluted)
$1.21
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFH
BFH
STE
STE
Q4 25
$975.0M
$1.5B
Q3 25
$971.0M
$1.5B
Q2 25
$929.0M
$1.4B
Q1 25
$970.0M
$1.5B
Q4 24
$925.0M
$1.4B
Q3 24
$983.0M
$1.3B
Q2 24
$939.0M
$1.3B
Q1 24
$991.0M
$1.1B
Net Profit
BFH
BFH
STE
STE
Q4 25
$192.9M
Q3 25
$188.0M
$191.9M
Q2 25
$139.0M
$177.4M
Q1 25
$138.0M
$145.7M
Q4 24
$173.5M
Q3 24
$2.0M
$150.0M
Q2 24
$133.0M
$145.4M
Q1 24
$134.0M
$-1.4M
Gross Margin
BFH
BFH
STE
STE
Q4 25
43.8%
Q3 25
44.2%
Q2 25
45.1%
Q1 25
43.3%
Q4 24
44.5%
Q3 24
43.6%
Q2 24
44.7%
Q1 24
40.2%
Operating Margin
BFH
BFH
STE
STE
Q4 25
4.9%
18.3%
Q3 25
20.2%
18.2%
Q2 25
18.7%
17.7%
Q1 25
20.3%
14.6%
Q4 24
-2.9%
17.9%
Q3 24
4.1%
16.5%
Q2 24
19.2%
14.5%
Q1 24
19.0%
22.0%
Net Margin
BFH
BFH
STE
STE
Q4 25
12.9%
Q3 25
19.4%
13.1%
Q2 25
15.0%
12.8%
Q1 25
14.2%
9.8%
Q4 24
12.7%
Q3 24
0.2%
11.3%
Q2 24
14.2%
11.4%
Q1 24
13.5%
-0.1%
EPS (diluted)
BFH
BFH
STE
STE
Q4 25
$1.21
$1.96
Q3 25
$3.96
$1.94
Q2 25
$2.94
$1.79
Q1 25
$2.78
$1.48
Q4 24
$0.08
$1.75
Q3 24
$0.05
$1.51
Q2 24
$2.66
$1.46
Q1 24
$2.70
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFH
BFH
STE
STE
Cash + ST InvestmentsLiquidity on hand
$3.6B
$423.7M
Total DebtLower is stronger
$4.3B
$1.9B
Stockholders' EquityBook value
$3.3B
$7.2B
Total Assets
$22.7B
$10.6B
Debt / EquityLower = less leverage
1.29×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFH
BFH
STE
STE
Q4 25
$3.6B
$423.7M
Q3 25
$3.8B
$319.2M
Q2 25
$3.8B
$279.7M
Q1 25
$4.2B
$171.7M
Q4 24
$4.0B
$155.2M
Q3 24
$3.5B
$172.2M
Q2 24
$4.1B
$198.3M
Q1 24
$3.8B
$207.0M
Total Debt
BFH
BFH
STE
STE
Q4 25
$4.3B
$1.9B
Q3 25
$3.8B
$1.9B
Q2 25
$4.2B
$1.9B
Q1 25
$5.1B
$1.9B
Q4 24
$5.6B
$2.0B
Q3 24
$4.6B
$2.2B
Q2 24
$2.2B
Q1 24
$3.1B
Stockholders' Equity
BFH
BFH
STE
STE
Q4 25
$3.3B
$7.2B
Q3 25
$3.3B
$7.0B
Q2 25
$3.2B
$7.0B
Q1 25
$3.1B
$6.6B
Q4 24
$3.1B
$6.4B
Q3 24
$3.1B
$6.6B
Q2 24
$3.2B
$6.4B
Q1 24
$3.0B
$6.3B
Total Assets
BFH
BFH
STE
STE
Q4 25
$22.7B
$10.6B
Q3 25
$21.7B
$10.4B
Q2 25
$21.8B
$10.4B
Q1 25
$22.4B
$10.1B
Q4 24
$22.9B
$10.0B
Q3 24
$21.7B
$10.2B
Q2 24
$22.1B
$10.1B
Q1 24
$22.3B
$11.1B
Debt / Equity
BFH
BFH
STE
STE
Q4 25
1.29×
0.27×
Q3 25
1.14×
0.27×
Q2 25
1.34×
0.27×
Q1 25
1.67×
0.29×
Q4 24
1.82×
0.32×
Q3 24
1.47×
0.33×
Q2 24
0.35×
Q1 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFH
BFH
STE
STE
Operating Cash FlowLast quarter
$568.0M
$298.2M
Free Cash FlowOCF − Capex
$199.5M
FCF MarginFCF / Revenue
13.3%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
1.55×
TTM Free Cash FlowTrailing 4 quarters
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFH
BFH
STE
STE
Q4 25
$568.0M
$298.2M
Q3 25
$605.0M
$287.8M
Q2 25
$526.0M
$420.0M
Q1 25
$393.0M
$260.8M
Q4 24
$479.0M
$332.8M
Q3 24
$456.0M
$250.7M
Q2 24
$477.0M
$303.7M
Q1 24
$447.0M
$254.8M
Free Cash Flow
BFH
BFH
STE
STE
Q4 25
$199.5M
Q3 25
$201.3M
Q2 25
$326.4M
Q1 25
$189.9M
Q4 24
$243.6M
Q3 24
$148.8M
Q2 24
$195.7M
Q1 24
$163.3M
FCF Margin
BFH
BFH
STE
STE
Q4 25
13.3%
Q3 25
13.8%
Q2 25
23.5%
Q1 25
12.8%
Q4 24
17.8%
Q3 24
11.2%
Q2 24
15.3%
Q1 24
14.6%
Capex Intensity
BFH
BFH
STE
STE
Q4 25
6.6%
Q3 25
5.9%
Q2 25
6.7%
Q1 25
4.8%
Q4 24
6.5%
Q3 24
7.7%
Q2 24
8.4%
Q1 24
8.2%
Cash Conversion
BFH
BFH
STE
STE
Q4 25
1.55×
Q3 25
3.22×
1.50×
Q2 25
3.78×
2.37×
Q1 25
2.85×
1.79×
Q4 24
1.92×
Q3 24
228.00×
1.67×
Q2 24
3.59×
2.09×
Q1 24
3.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFH
BFH

Segment breakdown not available.

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons